19/02/2024
What’s next for the novel oral polio vaccine type 2 (nOPV2) now that it’s been WHO-prequalified?

An interview with GPEI experts

09/01/2024
GPEI press release on nOPV2 prequalification

WHO grants prequalification to innovative polio vaccine, nOPV2, as nearly 1 billion doses are administered

30/03/2023
Two years since rollout of novel oral polio vaccine type 2 (nOPV2): How’s it all working out?

An interview with co-leads of GPEI’s nOPV Working Group on nOPV2 field use to date

30/05/2022
Faster, better, more equitable

World Health Assembly challenged to take urgent action before window of opportunity closes to eradicate polio; tackle cVDPVs with same urgen...

25/05/2022
The need for speed: polio outbreak response

Rapid action needed to effectively quash transmission

19/05/2022
Coffee With Polio Experts: Dr Ananda Bandyopadhyay

Ananda talks about development of the nOPV2 vaccine its pathway to rollout, and field performance

10/10/2021
Independent experts advise move to next use phase for novel oral polio vaccine type 2

The recommendation further advances nOPV2 as a critical new tool in the fight against circulating vaccine-derived poliovirus type 2 (cVDPV2)

27/08/2021
WHO AFRO Wild Polio Free Anniversary: A New Innovation to Tackle Polio Outbreaks

Learn how the type 2 novel oral polio vaccine (nOPV2) is being rolled out across Africa to help more sustainably address outbreaks of a non-...

10/06/2021
Countries reaffirm commitment to ending polio at launch of new eradication strategy

Renewed donor support critical to ending polio after recent rise in cases and COVID-19 setbacks

13/03/2021
Countries gear up to kick all forms of polio out of Africa, once and for all

To rapidly and sustainably stop outbreaks of circulating vaccine-derived poliovirus type 2 (cVDPV2), a modified vaccine, known as novel oral...

13/11/2020
Recommandation d’autorisation d’utilisation d’urgence pour un nouveau vaccin

Nouvel outil à utiliser pour lutter contre le PVDVc2